1. Home
  2. SLDB vs PACK Comparison

SLDB vs PACK Comparison

Compare SLDB & PACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLDB
  • PACK
  • Stock Information
  • Founded
  • SLDB 2013
  • PACK 1972
  • Country
  • SLDB United States
  • PACK United States
  • Employees
  • SLDB N/A
  • PACK N/A
  • Industry
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • PACK Containers/Packaging
  • Sector
  • SLDB Health Care
  • PACK Consumer Discretionary
  • Exchange
  • SLDB Nasdaq
  • PACK Nasdaq
  • Market Cap
  • SLDB 464.1M
  • PACK 464.0M
  • IPO Year
  • SLDB 2018
  • PACK N/A
  • Fundamental
  • Price
  • SLDB $5.49
  • PACK $5.58
  • Analyst Decision
  • SLDB Strong Buy
  • PACK Buy
  • Analyst Count
  • SLDB 10
  • PACK 3
  • Target Price
  • SLDB $15.00
  • PACK $7.17
  • AVG Volume (30 Days)
  • SLDB 1.0M
  • PACK 443.2K
  • Earning Date
  • SLDB 11-07-2025
  • PACK 10-30-2025
  • Dividend Yield
  • SLDB N/A
  • PACK N/A
  • EPS Growth
  • SLDB N/A
  • PACK N/A
  • EPS
  • SLDB N/A
  • PACK N/A
  • Revenue
  • SLDB N/A
  • PACK $380,700,000.00
  • Revenue This Year
  • SLDB N/A
  • PACK $11.38
  • Revenue Next Year
  • SLDB N/A
  • PACK $8.10
  • P/E Ratio
  • SLDB N/A
  • PACK N/A
  • Revenue Growth
  • SLDB N/A
  • PACK 10.38
  • 52 Week Low
  • SLDB $2.41
  • PACK $2.91
  • 52 Week High
  • SLDB $7.37
  • PACK $8.70
  • Technical
  • Relative Strength Index (RSI)
  • SLDB 48.24
  • PACK 53.86
  • Support Level
  • SLDB $5.48
  • PACK $5.10
  • Resistance Level
  • SLDB $6.09
  • PACK $5.60
  • Average True Range (ATR)
  • SLDB 0.37
  • PACK 0.29
  • MACD
  • SLDB -0.03
  • PACK -0.02
  • Stochastic Oscillator
  • SLDB 28.26
  • PACK 65.06

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

About PACK Ranpak Holdings Corp

Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. Geographically, it derives a majority of its revenue from Europe/Asia. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.

Share on Social Networks: